Molecules preferentially associated with effector T cells or regulatory T cells and methods of their use

Details for Australian Patent Application No. 2003282550 (hide)

International Classifications

Event Publications

25 March 2004 Complete Application Filed

Priority application(s): 60/417,243 09.10.02 US; 60/419,575 18.10.02 US; 60/417,103 09.10.02 US; 60/424,881 08.11.02 US; 60/424,777 08.11.02 US; 60/417,102 09.10.02 US

3 June 2004 Application Open to Public Inspection

Published as AU-B-2003282550

4 September 2008 Application Accepted

Published as AU-B-2003282550

11 September 2008 Alteration of Name

The name of the applicant has been altered to Tolerx, Inc.

25 September 2008 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 27 Aug 2008

8 January 2009 Standard Patent Sealed

3 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.